Literature DB >> 12544855

Neuro-ophthalmology of mitochondrial diseases.

Valérie Biousse1, Nancy J Newman.   

Abstract

PURPOSE OF REVIEW: To review recent data on mitochondrial diseases with emphasis on their neuro-ophthalmic manifestations. RECENT
FINDINGS: Numerous studies have associated mitochondrial diseases with neuro-ophthalmic manifestations. Although there has been an explosion of studies on the genetics of mitochondrial diseases over the past few years, pathogenesis is only partly understood and therapy remains very limited. Over the past year, new mutations in Leber's hereditary optic neuropathy have been reported, and at least three genes associated with autosomal dominant chronic progressive external ophthalmoplegia have been described. These findings allow a better definition of the specific genetic mutations and gene products as well as pathophysiology of Leber's hereditary optic neuropathy and chronic progressive external ophthalmoplegia. The current development of animal models allows a better understanding of the pathophysiology of human mitochondrial diseases.
SUMMARY: The afferent and efferent visual pathways within the central nervous system are frequently involved in mitochondrial diseases. Neuro-ophthalmic signs figure prominently and may be the presenting or even sole manifestation of these disorders. The four most common neuro-ophthalmic abnormalities seen in mitochondrial disorders are bilateral optic neuropathy, ophthalmoplegia with ptosis, pigmentary retinopathy, and retrochiasmal visual loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12544855     DOI: 10.1097/01.wco.0000053592.70044.57

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  9 in total

1.  [Kearns-Sayre syndrome : a mitochondrial disease (OMIM #530000)].

Authors:  W J Mayer; M Remy; G Rudolph
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

Review 2.  Disorders of the anterior visual pathways.

Authors:  S A Madill; P Riordan-Eva
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

3.  Diagnostic value of mitochondrial DNA mutation analysis in juvenile unilateral ptosis.

Authors:  Thorsten Okulla; Wolfram S Kunz; Thomas Klockgether; Rolf Schröder; Cornelia Kornblum
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-13       Impact factor: 3.117

4.  Orbital magnetic resonance imaging of extraocular muscles in chronic progressive external ophthalmoplegia: specific diagnostic findings.

Authors:  Maria Carolina Ortube; Rahul Bhola; Joseph L Demer
Journal:  J AAPOS       Date:  2006-10       Impact factor: 1.220

Review 5.  Toxic optic neuropathy.

Authors:  Anat Kesler; Pazit Pianka
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

6.  The role of mitochondrial haplogroups in primary open angle glaucoma.

Authors:  R Andrews; T Ressiniotis; D M Turnbull; M Birch; S Keers; P F Chinnery; P G Griffiths
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

7.  [Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome : interdisciplinary diagnosis and therapy].

Authors:  B Wabbels; N Ali; W S Kunz; P Roggenkämper; C Kornblum
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

8.  Electron microscopic findings in levator muscle biopsies of patients with isolated congenital or acquired ptosis.

Authors:  Bettina Wabbels; Josef A Schroeder; Beate Voll; Heiko Siegmund; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-24       Impact factor: 3.117

9.  Mitochondrial disorders with significant ophthalmic manifestations.

Authors:  Mona Al-Enezi; Hanan Al-Saleh; Murad Nasser
Journal:  Middle East Afr J Ophthalmol       Date:  2008-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.